An immunotherapy used against advanced non-small cell lung
cancer is being tested at MD Anderson for a different job: preventing
the disease from developing in people with pre-cancerous lung nodules.
The first-of-its-kind Phase II clinical trial is based on research into these precancerous growths by Jianjun Zhang, M.D., Ph.D., assistant professor of Thoracic/Head and Neck Medical Oncology.
How...
During MD Anderson’s recent Moon Shots Program event, a new clinical trial aimed at detecting lung cancer at an earlier stage was highlighted...